000 | 01788 a2200505 4500 | ||
---|---|---|---|
005 | 20250514181822.0 | ||
264 | 0 | _c20040429 | |
008 | 200404s 0 0 eng d | ||
022 | _a0264-410X | ||
024 | 7 |
_a10.1016/j.vaccine.2003.10.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBruge, Joëlle | |
245 | 0 | 0 |
_aClinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers. _h[electronic resource] |
260 |
_bVaccine _cMar 2004 |
||
300 |
_a1087-96 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Bacterial _xanalysis |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aAutoantibodies _xanalysis |
650 | 0 | 4 | _aColony Count, Microbial |
650 | 0 | 4 | _aCross Reactions |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunization |
650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
650 | 0 | 4 |
_aImmunoglobulin M _xanalysis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMeningococcal Infections _xprevention & control |
650 | 0 | 4 |
_aMeningococcal Vaccines _xadverse effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
650 | 0 | 4 |
_aNeural Cell Adhesion Molecules _ximmunology |
650 | 0 | 4 |
_aPolysaccharides _ximmunology |
650 | 0 | 4 | _aPrecipitin Tests |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aVaccines, Conjugate _xadverse effects |
700 | 1 | _aBouveret-Le Cam, Nancy | |
700 | 1 | _aDanve, Bernard | |
700 | 1 | _aRougon, Geneviève | |
700 | 1 | _aSchulz, Dominique | |
773 | 0 |
_tVaccine _gvol. 22 _gno. 9-10 _gp. 1087-96 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2003.10.005 _zAvailable from publisher's website |
999 |
_c14723757 _d14723757 |